INHIBITOR OF DEOXYHYPUSINE HYDROXYLASE FOR THE TREATMENT AND PREVENTION OF RESPIRATORY VIRUS INFECTIONS

The disclosure relates to deoxyhypusine hydroxylase (DOHH) inhibitors for use in treating or preventing respiratory virus infections, such as infection with coronaviruses, human rhinoviruses, influenza viruses, human parainfluenza viruses, respiratory syncytial viruses or human metapneumoviruses. La...

Full description

Saved in:
Bibliographic Details
Main Authors CHASE, Arthur, SORIAGA, Leah B, TSE, Winston C, STOKES, Neil Robert, GROSSE, Johannes, BARTHA, Istvan, TELENTI, Amalio
Format Patent
LanguageEnglish
French
Published 30.11.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to deoxyhypusine hydroxylase (DOHH) inhibitors for use in treating or preventing respiratory virus infections, such as infection with coronaviruses, human rhinoviruses, influenza viruses, human parainfluenza viruses, respiratory syncytial viruses or human metapneumoviruses. La divulgation concerne des inhibiteurs de désoxyhypusine hydroxylase (DOHH) destinés à être utilisés dans le traitement ou la prévention d'infections par le virus respiratoire, telles qu'une infection par des coronavirus, des rhinovirus humains, des virus de la grippe, des virus parainfluenza humains, des virus respiratoires syncytiaux ou des métapneumovirus humains.
Bibliography:Application Number: WO2023US67284